Promoted Content Promoted Content


Find Clinical Drug Development Pipelines & Deals | PipelineProspector


All Data

Filters Filter refresh
News Type filter
    Company filter
      Product Type filter
        Deal Size filter
          Upfront Payment filter

            Product Type Full Screen

            Companies Full Screen

            Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

            Contact the Supplier

            Lead Product(s): SACT-1

            Therapeutic Area: Oncology Product Name: Undisclosed

            Highest Development Status: Phase I/ Phase II Product Type: Undisclosed

            Partner/Sponsor/Collaborator: Alliance Global Partners

            Deal Size: $10.0 million Upfront Cash: Undisclosed

            Deal Type: Public Offering February 26, 2020


            Net proceeds from the offering will fund the continued research and development of its leading therapeutic candidates (including SACT-1 and ALS-4) into their respective clinical phases.